Burkert Francesco Robert, Niederreiter Lukas, Dichtl Wolfgang, Mayr Agnes, Virgolini Irene, Klauser Andrea, Weiss Günter, Bellmann-Weiler Rosa
Internal Medicine Department II, Medical University Innsbruck, Landeskrankenhaus Innsbruck, Anichstraße 35, 6020 Innsbruck, Austria.
Radiology Department, Medical University Innsbruck, Innsbruck, Austria.
Eur Heart J Case Rep. 2021 Jan 6;5(2):ytaa521. doi: 10.1093/ehjcr/ytaa521. eCollection 2021 Feb.
Since the first documented outbreak of a novel severe acute respiratory syndrome inducing Coronavirus in China at the end of 2019 the virus has spread to all continents, leading the WHO to declare a pandemic in March 2020. While this virus primarily targets the alveoli in the lungs, multiple authors have described an increased rate of thrombo-embolic events in affected patients. We present this case of a myocardial infarction with no obstructive coronary atherosclerosis in an otherwise healthy 48-year-old patient.
A 48-year-old female, presenting with chest pain radiating to her left shoulder with no cardiovascular risk factors other than genetic predisposition, was screened for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and tested positive. Although computed tomography angiography excluded obstructive coronary heart disease, cardiac magnetic resonance imaging showed an acute myocardial infarction with no obstructive coronary arteries of the inferior wall. The patient was treated with dual anti-platelet therapy, an angiotensin-converting-enzyme inhibitor and a statin, and assigned to a cardiac rehabilitation program.
We report a serious thrombo-embolic event during an oligosymptomatic SARS-CoV-2 infection in a healthy, young patient. While these two diseases may have occurred simultaneously, by chance, it is possible that the pro-thrombotic effects of the SARS-CoV-2 infection facilitated the infarction. This case further demonstrates the significant cardiovascular morbidity potentially caused by SARS-CoV-2.
自2019年底中国首次记录新型严重急性呼吸综合征冠状病毒疫情爆发以来,该病毒已蔓延至各大洲,导致世界卫生组织于2020年3月宣布全球大流行。虽然这种病毒主要攻击肺部的肺泡,但多位作者描述了受感染患者血栓栓塞事件的发生率增加。我们报告了一例在一名原本健康的48岁患者中发生的无阻塞性冠状动脉粥样硬化的心肌梗死病例。
一名48岁女性,除遗传易感性外无其他心血管危险因素,因胸痛放射至左肩前来就诊,经检测确诊为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)阳性。虽然计算机断层扫描血管造影排除了阻塞性冠心病,但心脏磁共振成像显示下壁急性心肌梗死且冠状动脉无阻塞。该患者接受了双联抗血小板治疗、血管紧张素转换酶抑制剂和他汀类药物治疗,并被安排参加心脏康复计划。
我们报告了一名健康年轻患者在SARS-CoV-2感染症状轻微期间发生的严重血栓栓塞事件。虽然这两种疾病可能偶然同时发生,但SARS-CoV-2感染的促血栓形成作用可能促成了心肌梗死。该病例进一步证明了SARS-CoV-2可能导致的重大心血管疾病。